Kurman RJ et al. |
Norethindrone acetate and estradiol-induced endometrial hyperplasia. |
2000 |
Obstet Gynecol |
pmid:10960628
|
Symons J et al. |
Vaginal bleeding in postmenopausal women taking low-dose norethindrone acetate and ethinyl estradiol combinations. The FemHRT Study Investigators. |
2000 |
Obstet Gynecol |
pmid:10960627
|
Flodgaard D et al. |
Two oral contraceptives with the same gestagen and different estrogen. A controlled clinical trial. |
1975 |
Contraception |
pmid:1095298
|
Grant C et al. |
Management of menorrhagia in primary care-impact on referral and hysterectomy: data from the Somerset Morbidity Project. |
2000 |
J Epidemiol Community Health |
pmid:10942454
|
Chaudhury RR |
Modern trends in contraceptive pharmacology. |
1975 |
J Med Assoc Thai |
pmid:1094081
|
Garza-Flores J and Stafford JE |
Solid-phase radioimmunoassay for norethisterone. |
1979 |
Clin. Chim. Acta |
pmid:109237
|
Dexeus S and Fernández-Cid A |
[Cytological changes produced by anovulatories and intrauterine devices]. |
1975 |
Acta Ginecol (Madr) |
pmid:1092123
|
Kovacs GT et al. |
A pre-coital pill? A preliminary in vitro study. |
2000 |
Br J Fam Plann |
pmid:10920297
|
von Kesserü E et al. |
Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns. |
2000 |
Contraception |
pmid:10906502
|
Bassol S et al. |
Mesigyna once-a-month combined injectable contraceptive: experience in Latin America. |
2000 |
Contraception |
pmid:10906501
|
Kaunitz AM |
Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial. |
2000 |
Contraception |
pmid:10906499
|
Winkler UH et al. |
Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study. |
2000 |
Fertil. Steril. |
pmid:10899490
|
Wentz AC et al. |
Gonadotropin responses following luteinizing hormone releasing hormone administration in normal subjects. |
1975 |
Obstet Gynecol |
pmid:1089927
|
Hamilton W |
Is norethisterone a lifestyle drug? The term lifestyle is not as clear as it may seem. |
2000 |
BMJ |
pmid:10896443
|
Lloyd D |
Is norethisterone a lifestyle drug? It's not a lifestyle drug in North Harrow. |
2000 |
BMJ |
pmid:10896442
|
Bryant G et al. |
Is norethisterone a lifestyle drug? Health is not merely the absence of disease. |
2000 |
BMJ |
pmid:10896441
|
Halleen JM et al. |
Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. |
2000 |
J. Bone Miner. Res. |
pmid:10893682
|
Gonzalo-Lumbreras R and Izquierdo-Hornillos R |
High-performance liquid chromatographic optimization study for the separation of natural and synthetic anabolic steroids. Application to urine and pharmaceutical samples. |
2000 |
J. Chromatogr. B Biomed. Sci. Appl. |
pmid:10892579
|
Spencer CP et al. |
Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women. |
2000 |
Metab. Clin. Exp. |
pmid:10877199
|
Ravinder P et al. |
Biological efficacy and plasma norethisterone levels of orally administered norethisterone enanthate in rat and hamster. |
1998 |
Indian J. Physiol. Pharmacol. |
pmid:10874348
|